compounded tirzepatide legal status 2025 Eli Lilly has filed lawsuits against compounders selling unapproved versions of its weight-loss drugs, Mounjaro and Zepbound. With the FDA reinforcing its stance, offering may carry serious risks. Are 🚨 FDA Moves to Permanently

Each release is matched with quality documentation through a documented verification path

If you are unsure whether you qualify, your provider or pharmacist can help submit a prior authorization request to confirm coverage

Rheumatology (Oxford) 2014

According to the October 2024 multi-society guidance from the American Society of Anesthesiologists (ASA), American Gastroenterological Association (AGA), American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE), and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), most patients can safely continue their GLP-1 medications before elective procedures with appropriate risk mitigation strategies